EVICEL Fibrin Sealant (Human) Rx Only. Manufacturer: Omrix Biopharmaceuticals Ltd. MDA blood bank, Sheba Hospital, Ramat-Gan, POB 888, Kiryat Ono 55000 Israel U.S. License No. 1603. Distributed by: Ethicon, Inc. P.O. Box 151, Somerville, NJ 08876-0151 USA. The Pressure Regulator System is positioned on the floor or on an IV pole and accepts medical gas (compressed air, nitrogen, CO2) from the central hospital system or from medical gas cylinders.
Publicado el 31 de octubre de 2012 · Inicio del retiro: 2 de julio de 2012
Resumen
FDA registra el retiro Z-0111-2013 de dispositivos médicos de Clase II, publicado el 31 de octubre de 2012 e iniciado el 2 de julio de 2012. Empresa responsable: Ethicon, Inc.; Estado: Finalizado; Cantidad reportada: 4800 pressure regulators distributed worldwide; 1500 distributed within the US; Lote: To include all lots and product codes for EVICEL and Omrix pressure regulators. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Ethicon and Omrix Biopharmaceuticals have received reports of air or gas embolism occuring in association with the use of spray devices employing a pressure regulator to administer EVICEL; these events appear to be related to the use of the spray device at higher-than-recommended pressures and/or in close proximity to the tissue surface. The field correction initiated is to provide the recommend
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Ethicon, Inc.
- Distribuidor
- Worldwide Distribution -- USA (nationwide) and the countries of Canada, European Union, Singapore, Israel, Mexico and Brazil.
- Lote
- To include all lots and product codes for EVICEL and Omrix pressure regulators.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDACoated VICRYL Polyglactin 910 Suture VIO 36IN(90CM) USP0(M3.5) S/A CT, Product Number J358H13 de noviembre de 2024
- FDAVICRYL (polyglactin 910) Suture - Indicated for use in general soft tissue approximation and/or ligation,26 de junio de 2024
- FDAPDS Plus Antibacterial (polydioxanone) Suture - Intended for use in general soft tissue approximation,26 de junio de 2024
- FDAMONOCRYL (poliglecaprone 25) Suture - Intended for use in general soft tissue approximation and/or ligation26 de junio de 2024
- FDASynchron Systems Synchron Calibrator Multi Calibrator Diskettes, Part Number 442600. The SYNCHRON31 de octubre de 2012
- FDAAdvanDx GNR Traffic Light PNA FISH, In Vitro Diagnostic for Culture Identification Kit for Escherichia31 de octubre de 2012
Preguntas sobre este retiro
¿EVICEL Fibrin Sealant (Human) Rx Only. Manufacturer: Omrix Biopharmaceuticals Ltd. MDA blood bank, Sheba Hospital, Ramat-Gan, POB 888, Kiryat Ono 55000 Israel U.S. License No. 1603. Distributed by: Ethicon, Inc. P.O. Box 151, Somerville, NJ 08876-0151 USA. The Pressure Regulator System is positioned on the floor or on an IV pole and accepts medical gas (compressed air, nitrogen, CO2) from the central hospital system or from medical gas cylinders. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0111-2013 el 31 de octubre de 2012. Peligro reportado: Ethicon and Omrix Biopharmaceuticals have received reports of air or gas embolism occuring in association with the use of spray devices employing a pressure regulator to administer EVICEL; these events appear to be related to the use of the spray device at higher-than-recommended pressures and/or in close proximity to the tissue surface. The field correction initiated is to provide the recommend
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter